Earnings Call · Q2 FY2024·2024-08-11

Q2 24EPS +4.35%·Rev n/aQ1 24EPS +11.50%·Rev n/aQ4 23EPS +29.04%·Rev n/aQ3 23EPS +12.21%·Rev n/a⚠ consensus missing

BioAtla, Inc. BCAB

Bruce Mackle — Investor Relations or Communications

Dr. Jay Short — Chairman, CEO and Co-Founder

Richard Waldron — Chief Financial Officer

0.0%1d on move date−0.4% vs SPY3d−4.8%5d+27.9%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more BCAB calls or request research access.

More BCAB calls Browse calls Request research access